You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 4, July 27, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the University of California, San Francisco, Medical Center
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (33)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Tobacco
 •Alert me on articles by topic

CLINICIAN’S CORNER
What to Do With a Patient Who Smokes

Steven A. Schroeder, MD

JAMA. 2005;294:482-487.

Despite the reality that smoking remains the most important preventable cause of death and disability, most clinicians underperform in helping smokers quit. Of the 46 million current smokers in the United States, 70% say they would like to quit, but only a small fraction are able to do so on their own because nicotine is so highly addictive. One third to one half of all smokers die prematurely. Reasons clinicians avoid helping smokers quit include time constraints, lack of expertise, lack of financial incentives, respect for a smoker’s privacy, fear that a negative message might lose customers, pessimism because most smokers are unable to quit, stigma, and clinicians being smokers. The gold standard for cessation treatment is the 5 As (ask, advise, assess, assist, and arrange). Yet, only a minority of physicians know about these, and fewer put them to use. Acceptable shortcuts are asking, advising, and referring to a telephone "quit line" or an internal referral system. Successful treatment combines counseling with pharmacotherapy (nicotine replacement therapy with or without psychotropic medication such as bupropion). Nicotine replacement therapy comes in long-acting (patch) or short-acting (gum, lozenge, nasal spray, or inhaler) forms. Ways to counter clinicians’ pessimism about cessation include the knowledge that most smokers require multiple quit attempts before they succeed, that rigorous studies show long-term quit rates of 14% to 20%, with 1 report as high as 35%, that cessation rates for users of telephone quit lines and integrated health care systems are comparable with those of individual clinicians, and that no other clinical intervention can offer such a large potential benefit.


Author Affiliation: Department of Medicine and Smoking Cessation Leadership Center, University of California, San Francisco.


RELATED LETTERS

Smoking Cessation
Jeffrey L. Kaufman
JAMA. 2005;294(19):2434.
EXTRACT | FULL TEXT  

Smoking Cessation
Frances R. Frankenburg
JAMA. 2005;294(19):2434.
EXTRACT | FULL TEXT  

Smoking Cessation—Reply
Steven A. Schroeder
JAMA. 2005;294(19):2435.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tobacco marketing awareness on youth smoking susceptibility and perceived prevalence before and after an advertising ban
Moodie et al.
Eur J Public Health 2008;0:ckn016v1-ckn016.
ABSTRACT | FULL TEXT  

Educational Disparities in Rates of Smoking Among Diabetic Adults: The Translating Research Into Action for Diabetes Study
Karter et al.
Am. J. Public Health 2008;98:365-370.
ABSTRACT | FULL TEXT  

The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline
Hollis et al.
Tobacco Control 2007;16:i53-i59.
ABSTRACT | FULL TEXT  

Tobacco quitlines: looking back and looking ahead
Anderson and Zhu
Tobacco Control 2007;16:i81-i86.
ABSTRACT | FULL TEXT  

Pharmacist-facilitated tobacco-cessation services in an inpatient setting
Leschisin and Martin
Am J Health Syst Pharm 2007;64:2386-2389.
FULL TEXT  

Pharmacologic Therapy: Novel Approaches for Chronic Obstructive Pulmonary Disease
Bailey and Tashkin
Proc Am Thorac Soc 2007;4:543-548.
ABSTRACT | FULL TEXT  

The Treatment of Smoking by US Physicians During Ambulatory Visits: 1994 2003
Thorndike et al.
Am. J. Public Health 2007;97:1878-1883.
ABSTRACT | FULL TEXT  

Healthcare provider smoking cessation advice among US worker groups
Lee et al.
Tobacco Control 2007;16:325-328.
ABSTRACT | FULL TEXT  

We Can Do Better -- Improving the Health of the American People
Schroeder
NEJM 2007;357:1221-1228.
FULL TEXT  

Emerging pharmacotherapies for smoking cessation
Garwood and Potts
Am J Health Syst Pharm 2007;64:1693-1698.
ABSTRACT | FULL TEXT  

Trials that Matter: Varenicline: A Designer Drug to Help Smokers Quit.
Schroeder and Sox
ANN INTERN MED 2006;145:784-785.
FULL TEXT  

Barriers to tobacco cessation.
Cunningham
CMAJ 2006;175:388-388.
FULL TEXT  

Tobacco still is oral health enemy number one
Schroeder
Journal of the American Dental Association 2006;137:144-148.
FULL TEXT  

Smoking Cessation
Kaufman
JAMA 2005;294:2434-2434.
FULL TEXT  

Smoking Cessation--Reply
Schroeder
JAMA 2005;294:2435-2435.
FULL TEXT  

Smoking Cessation
Frankenburg
JAMA 2005;294:2434-2434.
FULL TEXT  

Don't Wait for Them to Ask
Beckley
DOC News 2005;2:10-10.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.